Abstract
Hyperthermia is a key clinical outcome from recreational use of MDMA and is the leading cause of MDMA related hospital admissions as well as being linked to enhanced neurotoxicity [1, 2]. Animal models of ischemia which also display hyperthermia have shown an inflammatory process mediated by microglia and the release of the proinflammatory cytokine interleukin 1(IL-1 ) play a role in hyperthermicreactions [3]. Previous studies showed that microglia is prominently activated and IL-1 levels increased following MDMA administration [4], lending support to the hypothesis microglia play a role in MDMA induced hyperthermia. Minocycline is a tetracycline antibiotic with powerful anti-inflammatory properties, thought to be a result of its ability to attenuate glial activation [5]. This study examined whether preventing microglial activation through the administration of minocycline could limit or prevent the hyperthermia induced by MDMA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
